Homoeopathic Treatment of Fibrocystic Breast Diseases: A Case Series

Abstract

Fibrocystic changes are the most frequently occurring benign conditions of breast disease. Women of 20 to 50 years of age who frequently encounter various forms of stressors have the highest incidence of fibrocystic breast disease (FBD). In cases, where any palpable mass is detected after clinical examination, mammograms and ultrasonography (USG) are the most common investigative tools for the next level of assessment. Five patients with FBD were treated with homoeopathic medicines in our hospital within a period of 3 years under the project: ‘Homoeopathic management of benign neoplastic lesions of breast: an evidence-based study’. The diagnosis was based on clinical examination and USG. We followed standard homoeopathic guidelines for the final selection of medicines. Individualised homoeopathic medicines were used to treat these cases. The clinical assessment was done every month and objective assessment was done after serial USG reports at every 6-month interval. All the patients had notable improvements during treatment as inferred clinically as well as from the USG reports. Few associated symptoms improved too. Assessment of the causal attribution of the outcomes of the treated cases to the homoeopathic intervention was done using Modified Naranjo Criteria. ‘Definite’ association was found in four out of five cases and one case showed a ‘probable’ association. Therefore, we may conclude that homoeopathic treatment can be useful in treating FBD. Good-quality clinical trials are needed before making any firm recommendation.

Keywords

case report - fibrocystic breast diseases - homoeopathy - individualised homoeopathic medicine - MONARCH

Authors' Contribution

PS was involved in concept, literature search, clinical study and preparation of the article; PM contributed in the present modern medicine intervention and drafted the paper; RKM provided expert opinion regarding pathological investigation; RKJ was involved in ultrasonological examination and expert opinion; all the authors reviewed and approved the final paper.

Financial Support

The project was funded under the Extra-Mural Research Scheme of Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy, Government of India (vide letter no F. No-23-111/2009-10/CCRH/Tech/EMR/8758 dated 7 September 2009). Technical and administrative support was provided by the Central Council for Research in Homoeopathy.

Publication History

Article published online:
24 May 2022

• References

• 1 Malherbe K, Fatima S. Fibrocystic Breast Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020. Accessed Oct 26, 2021 at: https://www.ncbi.nlm.nih.gov/pubmed/31869073
• 2 Milosevic ZC, Nadrljanski MM, Milovanovic ZM, Gusic NZ, Vucicevic SS, Radulovic OS. Breast dynamic contrast enhanced MRI: fibrocystic changes presenting as a non-mass enhancement mimicking malignancy. Radiol Oncol 2017; 51 (02) 130-136
• 3 Ashbeck EL, Rosenberg RD, Stauber PM, Key CR. Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16 (03) 467-472
• 4 Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 2006; 11 (05) 435-449
• 5 Brkić M, Vujović S, Ivović M. et al. The role of E2/P ratio in the etiology of fibrocystic breast disease, mastalgia and mastodynia. Acta Clin Croat 2018; 57 (04) 756-761
• 6 Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D. Risk factors for benign proliferative breast disease. Int J Epidemiol 2000; 29 (04) 637-644
• 7 Baer HJ, Schnitt SJ, Connolly JL. et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomarkers Prev 2005; 14 (12) 2889-2897
• 8 Chen YY, Fang WH, Wang CC. et al. Examining the associations among fibrocystic breast change, total lean mass, and percent body fat. Sci Rep 2018; 8 (01) 9180
• 9 Aldemir K, Gurkan A, Yilmaz F, Kaymaz S, Demirel G. Psychosocial health level and quality of sexual life in women with fibrocystic breast disease. Int J Womens Health Wellness 2018; 4: 1-5 DOI: 10.23937/2474-1353/1510069.
• 10 Poggi M, Harney K. The breast. In: DeCherney A, Nathan L. eds. Current Obstetric and Gynecologic Diagnosis and Treatment. New York: Lange Medical Books/McGraw-Hill; 2003: 1097-1098
• 11 Schünemann HJ, Lerda D, Quinn C. et al; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast cancer screening and diagnosis: a synopsis of the European breast guidelines. Ann Intern Med 2020; 172 (01) 46-56
• 12 Tan KP, Mohamad Azlan Z, Rumaisa MP. et al. The comparative accuracy of ultrasound and mammography in the detection of breast cancer. Med J Malaysia 2014; 69 (02) 79-85
• 13 Mirhashemi SM, Sahmani M, Salehi B. et al. Metabolic response to omega-3 fatty acids and vitamin E co-supplementation in patients with fibrocystic breast disease: a randomized, double-blind, placebo-controlled trial. Arch Iran Med 2017; 20 (08) 466-473
• 14 Talaei A, Moradi A, Rafiei F. The evaluation of the effect of metformin on breast fibrocystic disease. Breast Dis 2017; 37 (02) 49-53
• 15 Chimane N, Yede A, Rupanavar S. Study on breast lump and its homoeopathic management. J Med Pharm Innovation. 2019; 6: 1-3
• 16 Shukla P, Misra P, Misra R. et al. Homoeopathic management of breast fibroadenoma – an open label, single arm, observational trial. Homoeopathic Links 2020; 33: 90-98
• 17 Lamba C, Gupta V, Haselen R. et al. Evaluation of the Modified Naranjo Criteria for assessing causal attribution of clinical outcome to homeopathic intervention as presented in case reports. Homeopathy 2020; 109 (04) 191-197
• 18 Boyle CA, Berkowitz GS, LiVolsi VA. et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. J Natl Cancer Inst 1984; 72 (05) 1015-1019
• 19 Moiloa MR, Brodie KJ, Roohani J. The efficacy of Phytolacca decandra in the treatment of fibroadenoma of the breast. Am J Homeopath Med 2006; 99: 116-119
• 20 Gupta G, Naveen G, Madhu C. Fibroadenoma of breast: a sonomammographical supported clinical study on the effect of homoeopathic drugs. Homoeopathy 2013; 4: 37-45
• 21 Parveen S. Individualized homoeopathic treatment of breast fibroadenoma: a case report. Indian J Res Homoeopathy 2018; 12: 46-52
• 22 Wadhwa B. A case report of fibroadenosis alleviated with homoeopathy. Indian J Res Homoeopathy. 2017; 11: 196-202
• 23 Parvu E. Trifolium pratense for breast disease: a case series. Homeopathy 2004; 93 (01) 45-50